Author

Gérard Zurawski

InsermORCID 0000-0002-0168-3523Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Organism:mouse· 1 Organism:non-human primate· 1

Frequent Co-Authors

Sandra ZurawskiiD· 2 shared Anne WijkhuiseniD· 1 shared Anne-Sophie GallouëtiD· 1 shared Asier Sáez‐CirióniD· 1 shared Aurélie BouteauiD· 1 shared Benoı̂t FavieriD· 1 shared Botond Z. IgyártóiD· 1 shared Florian MeurisseiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Sandra ZurawskiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Dual blockade of LILRB1 and LILRB2 enhances antiviral immune responses in SIV infection

Florian Meurisse, Sixtine Coindre, Anne Wijkhuisen, Romain Marlin, Laure Fournier Le Ray, Juliette Pons, Melyssa Yaugel-Novoa, Véronique Avettand-Fènoël, Laurent Abi‐Rached, Anne-Sophie Gallouët, Francis Relouzat, Maël Gourvès, Asier Sáez‐Cirión, Hisashi Arase, Gérard Zurawski, , Benoı̂t Favier

This study shows that blocking LILRB1 and LILRB2 with a dual-specific antibody enhances antiviral immune responses in SIV infection without adverse effects.

Advanced Science · Jul 30, 2026Peer-reviewedImmunology

Langerhans Cells Drive Tfh and B Cell Responses Independent of Canonical Cytokine Signals

Aurélie Bouteau, Zhen Qin, Sandra Zurawski, Gérard Zurawski, Botond Z. Igyártó

This study shows Langerhans cells drive Tfh and B cell responses without needing IL-6, type-I interferons, or ICOS-L, challenging the cytokine-centric model of T cell differentiation.

Frontiers in Immunology · Jul 18, 2025Peer-reviewedImmunology